Laidlaw Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Laidlaw. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Laidlaw.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
1/14/2019LaidlawUpgradesIntercept Pharmaceuticals (ICPT)Hold -> Buy$99.00 -> $130.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018LaidlawSet Price TargetCara Therapeutics (CARA)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018LaidlawInitiatesStrongbridge Biopharma (SBBP)Buy -> Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018LaidlawInitiatesTiziana Life Sciences (TLSA)Buy -> BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018LaidlawInitiatesTAIWAN LIPOSOME/S (TLC)Buy -> Buy $11.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018LaidlawSet Price TargetClearside Biomedical (CLSD)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018LaidlawDowngradesAvadel Pharmaceuticals (AVDL)Buy -> Hold $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018LaidlawInitiatesMolecular Templates (MTEM)Buy -> Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/10/2018LaidlawInitiatesAridis Pharmaceuticals (ARDS)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018LaidlawDowngradesIntercept Pharmaceuticals (ICPT)Buy -> Hold$90.00 -> $95.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018LaidlawInitiatesClearside Biomedical (CLSD)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018LaidlawRaises TargetViking Therapeutics (VKTX)Buy$10.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018LaidlawSet Price TargetCara Therapeutics (CARA)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018LaidlawInitiatesEleven Biotherapeutics (EBIO)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018LaidlawInitiatesMEI Pharma (MEIP)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2018LaidlawInitiatesAltheaDx (IDGX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/22/2018LaidlawReiteratesCytori Therapeutics (CYTX)Buy -> Buy $16.50MediumView Rating Details  Share on Twitter  Share on StockTwits
2/22/2018LaidlawInitiatesInterpace Diagnostics Group (IDXG)Buy -> Buy $4.50HighView Rating Details  Share on Twitter  Share on StockTwits
12/14/2017LaidlawInitiatesMarinus Pharmaceuticals (MRNS)Buy -> Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/29/2017LaidlawInitiatesFennec Pharmaceuticals (FRX)Buy C$22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/29/2017LaidlawInitiatesFennec Pharmaceuticals (FENC)Buy -> Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2017LaidlawLowers TargetNovaBay Pharmaceuticals (NBY)Buy -> Buy$10.00 -> $8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017LaidlawInitiatesEyepoint Pharmaceuticals (EYPT)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/1/2017LaidlawUpgradesIntercept Pharmaceuticals (ICPT)Hold -> Buy $90.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2017LaidlawLowers TargetDURECT (DRRX)Buy -> Buy$3.00 -> $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/13/2017LaidlawDowngradesPhaseRx (PZRX)Buy -> NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
10/10/2017LaidlawReiteratesFlexion Therapeutics (FLXN)Buy$35.00 -> $38.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/22/2017LaidlawLowers TargetIntercept Pharmaceuticals (ICPT)Hold -> Hold$118.00 -> $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/19/2017LaidlawInitiatesAthenex (ATNX)Buy $36.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/24/2017LaidlawInitiatesAIT Therapeutics (AITB)Buy -> Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017LaidlawReiteratesIonis Pharmaceuticals (IONS)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/1/2017LaidlawReiteratesIntercept Pharmaceuticals (ICPT)Hold$115.00 -> $119.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/25/2017LaidlawReiteratesiCAD (ICAD)Buy $11.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/21/2017LaidlawDowngradesRepros Therapeutics (RPRX)Buy -> NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
6/30/2017LaidlawLowers TargetCara Therapeutics (CARA)Buy$35.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/5/2017LaidlawUpgradesIntercept Pharmaceuticals (ICPT)Sell -> Hold $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/27/2017LaidlawInitiatesOnconova Therapeutics (ONTX)Buy -> Buy $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/4/2017LaidlawInitiatesAsterias Biotherapeutics (AST)Buy -> Buy $12.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2017LaidlawReiteratesCara Therapeutics (CARA)Buy -> Buy$20.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2017LaidlawInitiatesNovaBay Pharmaceuticals (NBY)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/10/2017LaidlawRaises TargetCara Therapeutics (CARA)Buy -> Buy$17.00 -> $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/30/2017LaidlawUpgradesEvoke Pharma (EVOK)Neutral -> Buy $8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/3/2017LaidlawReiteratesOpko Health (OPK)Buy$22.00 -> $19.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/27/2016LaidlawRaises TargetIonis Pharmaceuticals (IONS)Buy$59.00 -> $65.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/20/2016LaidlawInitiatesAxovant Sciences (AXON)Sell $7.50N/AView Rating Details  Share on Twitter  Share on StockTwits
10/10/2016LaidlawInitiatesVBI Vaccines (VBIV)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/6/2016LaidlawInitiatesGemphire Therapeutics (GEMP)Buy $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/11/2016LaidlawLowers TargetViking Therapeutics (VKTX)Buy$20.00 -> $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/5/2016LaidlawDowngradesIntercept Pharmaceuticals (ICPT)Buy -> Sell$345.00 -> $105.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/13/2016LaidlawInitiatesMabvax Therapeutics (MBVX)Buy $7.50N/AView Rating Details  Share on Twitter  Share on StockTwits
3/14/2016LaidlawLowers TargetBioDelivery Sciences International (BDSI)Buy$17.00 -> $11.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/29/2016LaidlawLowers TargetCara Therapeutics (CARA)Buy$30.00 -> $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/21/2016LaidlawLowers TargetAvadel Pharmaceuticals (AVDL)Buy$30.00 -> $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/10/2015LaidlawInitiatesAffimed (AFMD)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/9/2015LaidlawInitiatesCerecor (CERC)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/13/2015LaidlawInitiatesOpko Health (OPK)Buy $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/12/2015LaidlawInitiatesOpko Health (OPK)Buy $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/28/2015LaidlawReiteratesRepros Therapeutics (RPRX)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
4/7/2015LaidlawReiteratesCytori Therapeutics (CYTX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/26/2015LaidlawInitiatesAldeyra Therapeutics (ALDX)Buy $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/9/2014LaidlawRaises TargetIonis Pharmaceuticals (IONS) $65.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/25/2014LaidlawReiteratesIonis Pharmaceuticals (IONS)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
9/16/2014LaidlawInitiatesRexahn Pharmaceuticals (RNN)Buy $3.50N/AView Rating Details  Share on Twitter  Share on StockTwits
8/12/2014LaidlawInitiatesIonis Pharmaceuticals (IONS)Buy $52.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/30/2014LaidlawInitiatesIovance Biotherapeutics (IOVA)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
6/9/2014LaidlawReiteratesBioDelivery Sciences International (BDSI)Buy $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
6/2/2014LaidlawInitiatesRXi Pharmaceuticals (RXII)Buy $80.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/27/2014LaidlawInitiatesProtea Biosciences Group (PRGB)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
4/22/2014LaidlawInitiatesEvoke Pharma (EVOK)Buy $19.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/7/2014LaidlawInitiatesStratasys (SSYS)Buy $145.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/5/2014LaidlawRaises TargetOmnicell (OMCL)Buy$29.00 -> $34.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/5/2014LaidlawRaises TargetBioDelivery Sciences International (BDSI)Buy$12.00 -> $15.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/25/2014LaidlawInitiatesSurModics (SRDX)Buy $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/28/2014LaidlawRaises TargetOmnicell (OMCL)Buy$27.00 -> $29.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/24/2014LaidlawRaises TargetBioDelivery Sciences International (BDSI)Buy$9.00 -> $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Sunday at 06:00 PM ET.

MarketBeat Community Rating for Laidlaw

Community Ranking:  1.7 out of 5 (star half star)
Outperform Votes:  10,937 (Vote Outperform)
Underperform Votes:  20,923 (Vote Underperform)
Total Votes:  31,860
MarketBeat's community ratings are surveys of what our community members think about Laidlaw and other research firms. Vote "Outperform" if you believe Laidlaw's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Laidlaw's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel